Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes

Chinese Medical Journal

Volumn 115, Issue 7, 2002, Pages 972-978

  Chen, Jing ^a   Gu, Yong ^b   Lin, Fan ^a   Yang, Haichun ^a   Zhu, Weiyu ^b   Ma, Ji ^a,b   Lin, Shanyan ^a  

^a FUDAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Endothelin receptor antagonist; Hypertension; Renal injury

Indexed keywords

AMLODIPINE; ANGIOTENSIN; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CILAZAPRIL; COLLAGEN TYPE 4; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; FIBRONECTIN; LAMININ; SCLEROPROTEIN; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; ESSENTIAL HYPERTENSION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MEAN ARTERIAL PRESSURE; MONOTHERAPY; NONHUMAN; PROTEIN EXPRESSION; PROTEINURIA; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

AMLODIPINE; ANGIOTENSIN II; ANIMALS; CALCIUM CHANNEL BLOCKERS; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; DRUG THERAPY, COMBINATION; HYPERTENSION; KIDNEY; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036316317     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Structural and functional changes in diabetic glomerulopathy
2. Endothelin-1 transgenic mice develop renal cysts, interstitial fibrosis and glomerulosclerosis but not hypertension
3. The paracrine enothelin system: Pathophysiology and implications in clinical medicine
4. Gene expression for endothelin and their receptors in glomeruli of diabetic rats
5. The effect of aminoguanidine on gene expression of endothelins and their receptors in diabetic kidney tissue
6. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli
7. Endothelin antagonists for hypertension and renal disease
8. The transforming growth factor beta system in kidney disease and repair: Recent progress and future directions
9. Endothelin receptor subtype B mediates auto-induction of endothelin-1 in rat mesangial cells
10. Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a "natural factor" in cultured human endothelial cells
11. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells
12. Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade
13. Endothelin stimulates angiotensin II conversion in cultures pulmonary endothelial cells
14. Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis
15. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth